{"id":"https://openalex.org/W2938308951","doi":"https://doi.org/10.1182/blood-2018-99-114733","title":"Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease","display_name":"Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2938308951","doi":"https://doi.org/10.1182/blood-2018-99-114733","mag":"2938308951"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-114733","doi":"https://doi.org/10.1182/blood-2018-99-114733","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-114733","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068456972","display_name":"Jin Han","orcid":"https://orcid.org/0000-0003-0662-006X","observed_orcids":["https://orcid.org/0000-0003-0662-006X"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jin Han","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030174386","display_name":"Santosh L. Saraf","orcid":"https://orcid.org/0000-0002-8584-4194","observed_orcids":["https://orcid.org/0000-0002-8584-4194"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh L. Saraf","raw_affiliation_strings":["Sivision of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sivision of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048176086","display_name":"Michel Gowhari","orcid":"https://orcid.org/0000-0002-1958-278X","observed_orcids":["https://orcid.org/0000-0002-1958-278X"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michel Gowhari","raw_affiliation_strings":["Comprehensive sickle cell center, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive sickle cell center, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078221408","display_name":"Shivi Jain","orcid":"https://orcid.org/0000-0002-5869-0812","observed_orcids":["https://orcid.org/0000-0002-5869-0812"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivi Jain","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061639314","display_name":"Robert E. Molokie","orcid":"https://orcid.org/0000-0003-3623-7395","observed_orcids":["https://orcid.org/0000-0003-3623-7395"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Molokie","raw_affiliation_strings":["Department of Biopharmaceutical Sciences, College of Pharmacy; Division of Hematology/Oncology, University of Illinois, Chicago, IL","Department of Biopharmaceutical Sciences, College of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biopharmaceutical Sciences, College of Pharmacy; Division of Hematology/Oncology, University of Illinois, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]},{"raw_affiliation_string":"Department of Biopharmaceutical Sciences, College of Pharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012936630","display_name":"Victor R. Gordeuk","orcid":"https://orcid.org/0000-0003-4725-7295","observed_orcids":["https://orcid.org/0000-0003-4725-7295"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor R. Gordeuk","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068456972"],"corresponding_institution_ids":["https://openalex.org/I39422238"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"4699","last_page":"4699"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vaso-occlusive-crisis","display_name":"vaso-occlusive crisis","score":0.925000011920929},{"id":"https://openalex.org/keywords/opioid-consumption","display_name":"opioid consumption","score":0.8019999861717224},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.9589999914169312},{"id":"https://openalex.org/keywords/30-day-readmission","display_name":"30-day readmission","score":0.9079999923706055},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.6809999942779541},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.47699999809265137},{"id":"https://openalex.org/keywords/adults-with-sickle-cell-disease","display_name":"adults with sickle cell disease","score":0.6949999928474426},{"id":"https://openalex.org/keywords/predictors-of-readmission","display_name":"predictors of readmission","score":0.6970000267028809},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.41499999165534973},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9355000853538513},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5898661017417908},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.5691914558410645},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5547783374786377},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4973457157611847},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4826279580593109},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4463540315628052},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44319844245910645},{"id":"https://openalex.org/C2780976302","wikidata":"https://www.wikidata.org/wiki/Q4677915","display_name":"Acute chest syndrome","level":4,"score":0.4237942695617676},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3854801654815674},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3691929280757904},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.22030052542686462},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-114733","doi":"https://doi.org/10.1182/blood-2018-99-114733","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-114733","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897488046","https://openalex.org/W4396809935","https://openalex.org/W2520312178","https://openalex.org/W3037972375","https://openalex.org/W4384342395","https://openalex.org/W4310114278","https://openalex.org/W2530549775","https://openalex.org/W2570887992","https://openalex.org/W2562724180","https://openalex.org/W4417016116"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Vaso-occlusive":[2],"crisis":[3],"(VOC)":[4],"is":[5,501],"the":[6,21,44,104,153,184,189,192,205,209,232,262,268,276,282,289,294,303,306,339,351,359,363,368,408,445,450,461,470,535],"hallmark":[7],"complication":[8],"of":[9,16,46,87,106,158,191,247,284,305,334,370,391,415,452,493,520,629],"sickle":[10,507],"cell":[11,508],"disease":[12],"(SCD).":[13],"The":[14,85,222,271,330,413,514],"majority":[15],"SCD-related":[17],"healthcare":[18,33],"costs":[19],"in":[20,67,82,95,208,310,362,460,524],"United":[22],"States,":[23],"estimated":[24],"at":[25,103,112,128],"$2.4":[26],"billion":[27],"annually,":[28],"are":[29],"attributed":[30],"to":[31,36,62,151,240,260,267,281,358,436,526,631],"frequent":[32],"utilization":[34,90],"due":[35],"recurrent":[37],"VOC":[38,118],"(1-3).":[39],"Risk":[40],"factors":[41],"such":[42],"as":[43],"prescription":[45],"nonsteroidal":[47],"anti-inflammatory":[48],"drugs":[49],"(NSAIDs)":[50],"only":[51],"without":[52,132,143,235,353,463],"opioids,":[53],"older":[54],"age,":[55],"and":[56,127,140,176,188,228,313,323,397],"steroid":[57],"treatment":[58],"have":[59],"been":[60],"identified":[61],"be":[63],"associated":[64,502],"with":[65,137,219,225,264,361,472,503],"readmissions":[66],"pediatric":[68],"SCD":[69,100,291],"patients":[70,207,213,292,416,509],"(4,":[71],"5),":[72],"but":[73],"limited":[74],"data":[75],"exist":[76],"about":[77],"potential":[78],"predictors":[79],"for":[80,116,506,511],"readmission":[81,92,125,504,536],"adults":[83,101],"(6).":[84],"impact":[86],"inpatient":[88,167,177,194,372,454,495,521],"opioid":[89,172,179,196,198,374,376,427,456,458,497,499,522,529],"on":[91,326],"was":[93,120,202,258,273,298,342,378,441,466],"evaluated":[94],"this":[96,311],"study.":[97],"Methods:":[98],"Seventy":[99],"treated":[102,510],"University":[105],"Illinois":[107],"Hospital":[108],"from":[109,146,161,183,231,250],"2012-2016":[110],"had":[111,214],"least":[113,129],"one":[114,130,141,217],"hospitalization":[115,131,136,142,218],"uncomplicated":[117,512],"that":[119,489,517],"followed":[121],"by":[122,275,302],"a":[123,133,138,144,220,226,236,242,265,354,464,473,490],"30-day":[124],"(30-DR)":[126],"30-DR.":[134,221],"One":[135],"30-DR":[139,145,227,237,266,355,465,474],"each":[147],"patient":[148,234,419],"were":[149,181,238,315,318,325,356,403,483],"used":[150,239,418],"form":[152,241],"discovery":[154,210,364],"cohort":[155,244,365,447],"(a":[156,245],"total":[157,246],"140":[159],"hospitalizations":[160,224,230,249,352],"70":[162,206,290],"unique":[163,252],"patients).":[164,253],"Patient":[165],"characteristics,":[166],"laboratory":[168],"values,":[169],"outpatient":[170,336],"daily":[171,178,335],"use":[173,180],"before":[174,200,328,338,439,531],"admission,":[175,424],"collected":[182],"electronic":[185],"medical":[186],"records,":[187],"ratio":[190,369,451,492],"last":[193,371,453,494],"day":[195,373,455,496],"dose/home":[197,375,457,498],"dose":[199,333,377,428,459,500,523,530],"admission":[201,308,341],"calculated.":[203],"Among":[204,288],"cohort,":[211,312],"22":[212,251],"more":[215],"than":[216,469],"additional":[223],"matched":[229],"same":[233],"validation":[243,446],"62":[248],"A":[254],"Wilcoxon":[255],"signed-rank":[256],"test":[257],"performed":[259],"compare":[261],"ones":[263,269,360,438,471],"without.":[270],"study":[272],"approved":[274],"Institutional":[277],"Review":[278],"Board":[279],"prior":[280],"initiation":[283],"chart":[285],"review.":[286],"Results:":[287],"identified,":[293],"median":[295,331],"(IQR)":[296,332],"age":[297],"32.5":[299],"(25-44)":[300],"years":[301],"time":[304],"first":[307,340],"included":[309],"67%":[314],"females,":[316],"76%":[317],"HbSS":[319],"or":[320,399,425,432],"Sbeta0":[321],"genotype,":[322],"46%":[324],"hydroxyurea":[327],"admission.":[329],"opioids":[337,435],"170":[343],"(64-280)":[344],"mg":[345],"oral":[346,437],"morphine":[347],"equivalents":[348],"(OME).":[349],"When":[350],"compared":[357],"(Table":[366,411,448],"1),":[367,449],"lower":[379,468],"(1.5":[380],"vs.":[381,476],"1.9,":[382],"p=0.024),":[383],"whereas":[384,479],"other":[385,480],"relevant":[386,627],"clinical":[387,481],"variables":[388,482],"including":[389],"length":[390],"stay,":[392],"pain":[393],"score":[394],"upon":[395,401],"discharge,":[396],"hemoglobin":[398],"WBC":[400],"discharge":[402,440,532],"not":[404],"significantly":[405],"different":[406],"between":[407],"two":[409],"groups":[410],"1).":[412],"proportion":[414],"who":[417],"controlled":[420],"analgesia":[421],"(PCA)":[422],"during":[423,430],"underwent":[426],"tapering":[429,519],"hospitalizations,":[431],"converted":[433],"IV":[434],"also":[442,467],"comparable.":[443,484],"In":[444],"group":[462],"(1.4":[475],"2.0,":[477],"p=0.033),":[478],"Summary:":[485],"Here":[486],"we":[487],"showed":[488],"high":[491],"risk":[505],"VOC.":[513],"results":[515],"suggest":[516],"proper":[518],"reference":[525],"patient's":[527],"home":[528],"may":[533],"reduce":[534],"risk.":[537],"Reference:":[538],"K.":[539],"L.":[540,564,569,582],"Hassell,":[541],"Am":[542,557,576,618],"J":[543,558,577,619],"Prev":[544],"Med38,":[545],"S512":[546],"(Apr,":[547],"2010).":[548,562],"S.":[549,586],"Lanzkron,":[550],"C.":[551,554],"P.":[552],"Carroll,":[553],"Haywood,":[555],"Jr.,":[556],"Hematol85,":[559],"797":[560],"(Oct,":[561],"T.":[563,566],"Kauf,":[565],"D.":[567,585,598],"Coates,":[568],"Huazhi,":[570],"N.":[571],"Mody-Patel,":[572],"A.":[573,596,599,614],"G.":[574],"Hartzema,":[575],"Hematol84,":[578],"323":[579],"(Jun,":[580],"2009).":[581],"M.":[583,604,605,613],"Okorji,":[584],"Muntz,":[587],"R.":[588],"I.":[589],"Liem,":[590],"Pediatr":[591,607],"Blood":[592,608],"Cancer64,":[593],"(May,":[594,623],"2017).":[595,624],"Sobota,":[597],"Graham,":[600],"E.":[601],"J.":[602],"Neufeld,":[603],"Heeney,":[606],"Cancer58,":[609],"61":[610],"(Jan,":[611],"2012).":[612],"Brodsky":[615],"et":[616],"al.,":[617],"Med130,":[620],"601":[621],"e9":[622],"Disclosures":[625],"No":[626],"conflicts":[628],"interest":[630],"declare.":[632]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-04-25T00:00:00"}